Ironwood Pharmaceuticals to Host First Quarter 2012 Investor Update Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host
its first quarter 2012 investor update conference call and webcast at
8:30 a.m. Eastern Time on Tuesday, May 1, 2012. Individuals interested
in participating in the call should dial (877) 643-7155 (U.S. and
Canada) or (914) 495-8552 (international) using the conference ID number
74951581. To access the webcast, please visit the investors section of
Ironwood's website at www.ironwoodpharma.com
at least 15 minutes prior to the start of the call to ensure adequate
time for any software downloads that may be required.
The call will be available for replay via telephone starting May 1, 2012
at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m.
Eastern Time on May 8, 2012. To listen to the replay, dial (855)
859-2056 (U.S. and Canada) or (404) 537-3406 (international) using
conference ID number 74951581. The archived webcast will be available on
Ironwood's website for 14 days beginning approximately one hour after
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's GC-C agonist, is an investigational
drug for the treatment of irritable bowel syndrome with constipation
(IBS-C) and chronic constipation. The efficacy portion of linaclotide's
development program has been completed and supports the recently
submitted NDA submission for both indications, as well as the MAA
submission in Europe for the IBS-C indication. Ironwood also has a
growing pipeline of additional drug candidates in earlier stages of
development. Ironwood is located in Cambridge, Mass. To learn more,
Ironwood Pharmaceuticals, Inc.
Meredith Kaya, 617-374-5082
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media
Close window | Back to top